USPTO 2015–2025 USPTO PatentsView US Corporation

The Procter & Gamble Plaza

USPTO PatentsView assignee record - 29 granted patents across 27 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, The ranks #10,789 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 27 technology areas.

#10,789
of 49,997 US assignees by volume
Top 41%
by Innovation Score (38.3/100)
13.0
avg claims per patent
-35%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10789 · US Corporation #10,789 · 29 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-SMALL 29 grants
  • UPPER-Q #10,789/49,997
  • PHOTO-FINISH Technical Consumer…
  • CPC-FOCUS A61F · 27 areas
  • INNOV-THIN 38.3/100
  • CLAIMS-RICH 13.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DOWN -35% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Technical Consumer Products, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How The’s 38.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around The

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows The's Innovation Score is 38.3/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for The?

Each dot is one of The’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). The’s own 13.0 claims/patent is at or below the 15.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

The vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 28.92929.1 0510152025 Granted patents (volume) Avg claims / patent Technical Consumer Products, Inc. - 29, 19.9Technical Consume…Telair International GmbH - 29, 14.31Telair Internatio…Tenstorrent Inc. - 29, 23.28TenstorrentThe Patent Well LLC - 29, 22.03The Patent WellThe Q, LLC - 29, 7.62The QThe Ridge Wallet LLC - 29, 4.1The Ridge WalletTipper Tie, Inc. - 29, 15.83Tipper TieTitan Spine, LLC - 29, 19.55Titan SpineThe Procter & Gamble Plaza - 29, 12.97The Procter & Gam…
The vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where The's grants concentrate

The Procter & Gamble Plaza is a focused PatentsView assignee: 27 CPC subclasses with 51.7% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (7 grants) versus a trough of 1 in 2016. By volume, The sits between Technical Consumer Products, Inc. and Titan Spine, LLC.

The's three-year grant acceleration

The Procter & Gamble Plaza shows 1 grants in 2022–2024 against only 17 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at The's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows The holds 29 patents at rank #10,795, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near The

By rank, the assignees closest to #10,795 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in The's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for The, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), The ranks #428 of 3,082 assignees by patent count in that subclass.

The's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 201520162017201820192020202120242025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
The Procter & Gamble Plaza patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 10.3%
2016 1 3.4%
2017 3 10.3%
2018 3 10.3%
2019 7 24.1%
2020 5 17.2%
2021 5 17.2%
2024 1 3.4%
2025partial year 1 3.4%

Which technologies does The Procter & Gamble Plaza patent most?

Top 15 of 27 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

The Procter & Gamble Plaza's patent record in context - here's where to go next.

  • The Procter & Gamble Plaza's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 51.7% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #10,789 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare The Procter & Gamble Plaza against Technical Consumer Products, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 38.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.